https://health.economictimes.indiatimes.com/news/pharma/astrazeneca-sells-some-rights-to-nexium-vimovo-to-grunenthal/66427329
AstraZeneca sells some rights to Nexium, Vimovo to Grunenthal, ETHealthworld
Nexium, a proton pump inhibitor developed by AstraZeneca, has lost patent protection in the majority of global markets, while Vimovo is protected in most...
astrazenecasellsrightsnexiumvimovo
https://www.news-medical.net/news/20100526/POZEN-receives-milestone-payment-from-AstraZeneca-for-FDA-approval-of-VIMOVO.aspx
POZEN receives milestone payment from AstraZeneca for FDA approval of VIMOVO
Jun 24, 2019 - POZEN Inc., announced today the receipt of a $20 million milestone payment from AstraZeneca for the U.S. Food and Drug Administration approval of VIMOVO...
milestone paymentfda approvalreceives